All In Biotech

Drug Trial Radar · NCT05837897

A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease

A Phase 3, Multicenter, Randomized, Parallel-Group, Double-blind, Placebo-Controlled Induction Study Followed by an Open-label Extension Period to Evaluate the Efficacy and Safety of Intravenous Vedolizumab (300 mg) Infusion Treatment in Subjects in China With Moderately to Severely Active Crohn's Disease

Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 408 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

408

Planned (sponsor's estimate)

Start

Jun 16, 2023

Primary completion

Mar 8, 2030

Study completion May 30, 2031

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
May 1, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study to evaluate vedolizumab for injection (300 mg) as a safe and active treatment for Crohn's Disease in adults in China. Participants will receive an injection of Vedolizumab 300 mg at scheduled weeks 0, 2, and 6, and starting at week 14, every 8 weeks over 58 weeks or starting at week 18, every 4 weeks over 54 weeks. There will be up to 20 study visits over 58 weeks to complete assessments.

Conditions

  • Crohn's Disease

Interventions

  • Vedolizumab IVDrug

    Vedolizumab IV infusion

  • PlaceboDrug

    Vedolizumab placebo-matching IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving Clinical Response at Week 14Time frame: Up to Week 14

Locations

43 sites in 1 country. Site status is shown where the registry gives one.

  • The Second Hospital of Anhui Medical University

    Hefei, Anhui, China · Recruiting

  • Yijishan Hospital of Wannan Medical College

    Wuhu, Anhui, China · Recruiting

  • Peking University First Hospital - Changqiao Campus

    Beijing, Beijing Municipality, China · Completed

  • Peking University Third Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, China · Recruiting

  • Lanzhou University Second Hospital

    Lanzhou, Gansu, China · Recruiting

  • The First People's Hospital of Foshan

    Foshan, Guangdong, China · Recruiting

  • The First Affiliated Hospital, Sun Yat-sen University - Main

    Guangzhou, Guangdong, China · Recruiting

  • Guangzhou First People's Hospital

    Guangzhou, Guangdong, China · Recruiting

  • The Second Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China · Recruiting

  • The Third Affiliated Hospital, Sun Yat-Sen University

    Guangzhou, Guangdong, China · Completed

  • The Sixth Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China · Recruiting

  • Huizhou Central People's Hospital

    Huizhou, Guangdong, China · Recruiting

  • Qingyuan People's Hospital

    Qingyuan, Guangdong, China · Completed

  • The University of Hong Kong - Shenzhen Hospital

    Shenzhen, Guangdong, China · Recruiting

  • The Fifth Affiliated Hospital Sun Yat-Sen University

    Zhuhai, Guangdong, China · Recruiting

  • The Second Hospital of Hebei Medical University - Main

    Shijiazhuang, Hebei, China · Completed

  • The 2nd Affliated Hospital of Harbin Medical University

    Haerbin, Heilongjiang, China · Recruiting

  • Nanyang First People's Hospital

    Nanyang, Henan, China · Recruiting

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology

    Wuhan, Hubei, China · Recruiting

  • Renmin Hospital of Wuhan University - Main Campus

    Wuhan, Hubei, China · Recruiting

  • The Second Xiangya Hospital of Central South University

    Changsha, Hunan, China · Recruiting

  • Changzhou No.2 People's Hospital - Yanling Campus

    Changzhou, Jiangsu, China · Recruiting

  • Zhongda Hospital, Affiliated to Southeast University

    Nanjing, Jiangsu, China · Recruiting

  • Changshu No.2 People's Hospital

    Suzhou, Jiangsu, China · Recruiting

  • Xuzhou Central Hospital

    Xuzhou, Jiangsu, China · Completed

  • Yancheng No.1 People's Hospital

    Yancheng, Jiangsu, China · Recruiting

  • Affiliated Hospital of Jiangsu University

    Zhenjiang, Jiangsu, China · Recruiting

  • The Second Affiliated Hospital of Nanchang University - Donghu Campus

    Nanchang, Jiangxi, China · Recruiting

  • Shengjing Hospital of China Medical University - Nanhu Campus

    Shenyang, Liaoning, China · Recruiting

  • People's Hospital of Ningxia Hui Aotonomous Region

    Yinchuan, Ningxia, China · Completed

  • Yantai Yuhuangding Hospital

    Yantai, Shandong, China · Completed

  • Zhongshan Hospital Fudan University

    Shanghai, Shanghai Municipality, China · Completed

  • Shanghai East Hospital - Main

    Shanghai, Shanghai Municipality, China · Recruiting

  • Shanghai Changhai Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China · Recruiting

  • The First People's Hospital of Yunnan Province

    Kunming, Yunnan, China · Recruiting

  • The First Affiliated Hospital, Zhejiang University School of Medicine - Qingchun Campus - PPDS

    Hangzhou, Zhejiang, China · Recruiting

  • The First Affiliated Hospital of Ningbo University - Fangqiao Campus

    Ningbo, Zhejiang, China · Recruiting

  • People's Hospital of Quzhou

    Quzhou, Zhejiang, China · Completed

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.